Oncology & Cancer

New genetic test can improve ovarian cancer treatment

A genetic test developed in a study at the University of Helsinki and Helsinki University Hospital identifies ovarian cancer patients who benefit from PARP inhibitors, a treatment option.

page 4 from 40